Vogersa GM 2mg/500mg/0.3mg Tablet SR
Marketer
Ersa Lifesciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Vogersa GM 2mg/500mg/0.3mg Tablet SR
Diabex-Trio 2mg/500mg/0.3mg extended-release tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabex-Trio should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight control as directed by your doctor. Lifestyle modifications are vital for effective diabetes management. Hypoglycemia (low blood sugar) is a common adverse effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them promptly. Maintain regular mealtimes and always carry a quick-acting glucose source, such as sweets or juice. Alcohol consumption elevates hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any history of heart disease before commencing treatment, as it may be inappropriate. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to assess blood cell counts and liver function.
Uses of Vogersa GM 2mg/500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vogersa GM 2mg/500mg/0.3mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vogersa GM 2mg/500mg/0.3mg Tablet SR whole; do not break, crush, or chew it. Administer on an empty stomach.
Common Side effects of Vogersa GM 2mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Vogersa GM 2mg/500mg/0.3mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Vogersa GM 2mg/500mg/0.3mg Tablet SR whole; do not chew, crush, or divide it. Administer on an empty stomach.
How Vogersa GM 2mg/500mg/0.3mg Tablet SR works:
Vogersa GM SR tablets (2mg/500mg/0.3mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Vogersa GM 2mg/500mg/0.3mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Vogersa GM 2mg/500mg/0.3mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
Using Vogersa GM 2mg/500mg/0.3mg SR tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Vogersa GM 2mg/500mg/0.3mg Tablet SR, as its use may be unsafe. Individuals with severe kidney impairment should not use this medication; medical consultation is advised.
LiverCAUTION
Exercise caution when prescribing Vogersa GM 2mg/500mg/0.3mg SR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, initiate treatment with a reduced Vogersa GM 2mg/500mg/0.3mg SR tablet dosage; the medication is contraindicated in those with severe liver disease.
What if you forget to take Vogersa GM 2mg/500mg/0.3mg Tablet SR :
Should you forget to take your Vogersa GM 2mg/500mg/0.3mg Tablet SR, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Vogersa GM 2mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently